Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intratympanic dexamethasone added to standard therapy for Bell's palsy
IRCT20200314046769N1Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Jan 2018
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of dexamethasone, prednisolone and aciclovir in Bell's palsy (2 arms), sponsored by Tehran University of Medical Sciences. Primary endpoint: Change in Bell's palsy grade. Started Jan 2018; status: completed.
02
Drugs
dexamethasoneprednisoloneaciclovir
03
Conditions
Bell's palsy
Beyond the preview
Go deeper on IRCT20200314046769N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20200314046769N1.